CSI Market
Sign In | Register

Theralink Technologies Inc (OBMP) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access OBMP Annual Cash Flow →
The quarterly cash flow data below helps track how Theralink Technologies Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
3 Months 		(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Operating Activities
Income-19.05
Depreciation & amortization0.05
Amortization of Other Assets3.02
Accretion Expense0.04
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.03
Increase (Decrease) in Materials and Supplies0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Contributions To Capital By Related Parties Expenses-
Contributions To Capital By Related Party Forgiveness Of Debt-
Interest Expense-
Derivative Gain Loss On Derivative Net12.95
Noncash Default Interest Expense-
Extinguishment Of Debt Amount-
Impairment Loss Discontinued Operations And Disposal Of Discontinued Operations-
Increase Decrease In Assets Of Discontinued Operations-
Stock Issued For Services-
Lease Costs-
Operating Lease Expense-
Non Cash Lease Cost0.01
Marketable Securities Unrealized Gain Loss0.00
Litigation Settlement Expense-
Increase Decrease In Contract With Customer Liability0.00
Operating Lease Lease Income-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.75
Increase (Decrease) in Accounts Payable0.20
Increase (Decrease) in Accrued Liabilities0.00
Increase (Decrease) in Security Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.05
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.96
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Capitalized Computer Software Additions-
Acquisition Of Property And Equipment Discontinued Operations-
Decrease In Cash Upon Disposal Of Business-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Increase Decrease In Bank Overdraft-
Proceeds Of Notes Payable Related Party-
Proceeds From Convertible Debt Related Party-
Repayment Of Financed Lease-
Finance Lease Principal Payments-0.01
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.01
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.96
Total Cash Flow-0.97
4 historic quarters locked

Sign in to unlock the full Theralink Technologies Inc cash flow history.

Sign In Create Free Account

About Theralink Technologies Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20231231)
  • Filed with the SEC: February 20, 2024
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-24-007204

Figures are derived from filed reports and may be restated. Historical data is subject to revision.